Background illustration for clinical trials search

Leukemia Clinical Trials

Browse 1,314 Leukemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

for
NK-Cell Lymphoma, NK-Cell Leukemia, Peripheral T Cell Lymphoma
Location: Valhalla NY, Columbus OH, Grand Rapids MI,
Sponsor: New York Medical College

Sex: All

Age: 1 - 31

Code: NCT03719105

Early_phase1, Recruiting

Tissue Collection for Studies of Lymph Cancer

for
Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT01676805

Recruiting

A Telehealth Advance Care Planning Intervention

for
Myeloid Malignancy, Acute Myeloid Leukemia,
Location: Rochester NY
Sponsor: University of Rochester

Sex: All

Age: 60+

Code: NCT05875805

Recruiting

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

for
Haematological Malignancy, Acute Myeloid Leukemia,
Location: Philadelphia PA, Bethesda MD, Atlanta GA,
Sponsor: CellCentric Ltd.

Sex: All

Age: 18+

Code: NCT04068597

Phase1, Phase2, Recruiting

BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)

for
Acute Leukemia, MDS
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18 - 70+

Code: NCT04187105

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing

for
Acute Leukemia, Leukemia
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT06907797

Recruiting

Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

for
Acute Promyelocytic Leukemia With PML-RARA
Location: Nassau Bay TX, Houston TX, The Woodlands TX,
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 10+

Code: NCT01409161

Phase2, Recruiting

Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors

for
Lymphoblastic Leukemia, Cancer Survivors, Aplastic Anemia,
Location: Philadelphia PA, Memphis TN, Duarte CA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 10 - 30

Code: NCT05194397

Phase2, Recruiting

Allo HSCT Using RIC and PTCy for Hematological Diseases

for
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia,
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 0 - 70+

Code: NCT05805605

Phase2, Recruiting

A Study of Ruxolitinib and Duvelisib in People With Lymphoma

for
T-cell Lymphomas, NK-Cell Lymphomas,
Location: Boston MA, Commack NY, Uniondale NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05010005

Phase1, Recruiting

A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia

for
Acute Myeloid Leukemia
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05748197

Phase1, Recruiting

A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)

for
Philadelphia-Negative ALL, Philadelphia-Positive ALL,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 17+

Code: NCT06287528

Phase1, Recruiting

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Boston MA, Hampton VA, Greenville NC, York PA,
Sponsor: Loxo Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06588478

Phase2, Recruiting

A Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)

for
Acute Myeloid Leukemia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 2 - 18

Code: NCT06191978

Phase1, Recruiting

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia,
Location: Halifax, Portland ME, Scarborough ME, South Portland ME,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554406

Phase2, Recruiting

Hairy Cell Leukemia Patient Data Registry

for
Leukemia, Other
Location: Rochester NY, Miami Beach FL, Miami FL, Columbus OH,
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT02560883

Recruiting

Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms

for
Recurrent Chronic Myelomonocytic Leukemia,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05549661

Phase1, Recruiting

Binimetinib for People With Relapsed/Refractory BRAF Wild Type Hairy Cell Leukemia and Variant

for
Hairy Cell Leukemia
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04322383

Phase2, Recruiting

IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)

for
Acute Myeloid Leukemia
Location: Chapel Hill NC, Columbus OH, Dallas TX, Aurora CO
Sponsor: Alice Mims

Sex: All

Age: 18+

Code: NCT05401097

Phase2, Recruiting

Study of Olverembatinib (HQP1351) in Patients With CML-CP

for
Chronic Myeloid Leukemia, CML, CML, Chronic Phase
Location: Shirley NY, Hackensack NJ, New Brunswick NJ,
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT06423911

Phase3, Recruiting

What are clinical trials for leukemia?

Clinical trials for leukemia are research studies designed to evaluate new treatments, therapies, or diagnostic methods for different types of leukemia, a group of cancers that affect the blood and bone marrow. These trials aim to discover more effective ways to treat leukemia, manage its symptoms, and improve patient outcomes. They may involve testing new drugs, combinations of existing treatments, targeted therapies, immunotherapies, or novel approaches like gene therapy.

Why are leukemia clinical trials important?

Leukemia clinical trials are crucial because they drive advancements in treatment by testing new therapies, improving existing ones, and exploring novel approaches to manage and potentially cure the disease. These trials provide essential data on the safety and effectiveness of new treatments, which can lead to better outcomes and fewer side effects compared to current options.

Types of clinical trials for leukemia

Why participate in a leukemia clinical trial

Who can participate in a clinical trial for leukemia?

How to enroll in a leukemia clinical trial